BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23135775)

  • 1. Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.
    Di Paolo V; Russo I; Boldrini R; Ravà L; Pezzullo M; Benedetti MC; Galardi A; Colletti M; Rota R; Orlando D; Crocoli A; Peinado H; Milano GM; Di Giannatale A
    BMC Cancer; 2018 Jan; 18(1):31. PubMed ID: 29304781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting endothelial PDGFR-β facilitates angiogenesis-associated bone formation through the PAK1/NICD axis.
    Lin H; Lin R; Hou J; Zhu C; Liu G; Lin Y; Su J; Yang M; Yang B; Ma Y; Cheng C; Deng M; Yu B; Xu T; Wu H; Cui Z
    J Cell Physiol; 2024 May; ():. PubMed ID: 38721633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biology of ependymomas and emerging novel therapies.
    Saleh AH; Samuel N; Juraschka K; Saleh MH; Taylor MD; Fehlings MG
    Nat Rev Cancer; 2022 Apr; 22(4):208-222. PubMed ID: 35031778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma.
    Seo SH; Paul SK; Shikder M; Khanam M; Ghosh P; Hasib TA; Ahmed KA; Sikdar S; Uddin MJ; Kwon Y
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGFR-β
    Hu G; Huang L; Zhong K; Meng L; Xu F; Wang S; Zhang T
    Aging (Albany NY); 2021 May; 13(10):13693-13707. PubMed ID: 33946048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.
    Xu J; Lv H; Zhang B; Xu F; Zhu H; Chen B; Zhu C; Shen J
    J Thorac Dis; 2019 Jul; 11(7):3015-3029. PubMed ID: 31463131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA-Induced Early Onco/Suppressor Gene Expression with Tissue-Specificity in Mice.
    Gergely PA; Murnyák B; Bencze J; Kurucz A; Varjas T; Gombos K; Hortobágyi T
    Biomed Res Int; 2019; 2019():8670398. PubMed ID: 30882001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
    Xu X; Zhang F; Chen X; Ying Q
    Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the PDGF signaling pathway in tumor treatment.
    Heldin CH
    Cell Commun Signal; 2013 Dec; 11():97. PubMed ID: 24359404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor vessel biology in pediatric intracranial ependymoma.
    Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
    J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics.
    Board R; Jayson GC
    Drug Resist Updat; 2005; 8(1-2):75-83. PubMed ID: 15939344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma.
    Moreno L; Popov S; Jury A; Al Sarraj S; Jones C; Zacharoulis S
    J Neurooncol; 2013 Jan; 111(2):169-76. PubMed ID: 23135775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors.
    Virág J; Kenessey I; Haberler C; Piurkó V; Bálint K; Döme B; Tímár J; Garami M; Hegedűs B
    Pathol Oncol Res; 2014 Apr; 20(2):417-26. PubMed ID: 24190638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of Platelet-derived Growth factor receptors (PDGFRs) and their correlation with overall survival of patients with ovarian cancer.
    Szubert S; Moszynski R; Szpurek D; Romaniuk B; Sajdak S; Nowicki M; Michalak S
    Ginekol Pol; 2019; 90(5):242-249. PubMed ID: 30977516
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.